Autoren

David Mulder

Senior Associate

Read More

Christian Dekoninck

Partner

Read More

Adrian Toutoungi

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Dr. Angela Knierim

Senior Associate

Read More

JUDr. Barbora Dubanská, LL.M., MHA, Ph.D.

Partner

Read More

Dr. Agnieszka Sztoldman

Senior Associate

Read More
Autoren

David Mulder

Senior Associate

Read More

Christian Dekoninck

Partner

Read More

Adrian Toutoungi

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Dr. Angela Knierim

Senior Associate

Read More

JUDr. Barbora Dubanská, LL.M., MHA, Ph.D.

Partner

Read More

Dr. Agnieszka Sztoldman

Senior Associate

Read More

23. November 2020

Pharmaceutical patent law – 2 von 2 Insights

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

  • Quick read

Which extraordinary regulations have been put in place for speeding up clinical trials in emergency situations like the current coronavirus pandemic? And how is early access to new medicines warranted under such circumstance?

The second part of the two-part series ‘Pharmaceutical Patent Law in Times of Crisis: A Comparative Study’, written for the European Intellectual Property Review by our international team, addresses these questions and more on both a broad, European level and from the perspective of six national jurisdictions.
 

Read the article here

In dieser Serie

Patents Technology & Life Sciences

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

Quick read

von Mehrere Autoren

Patents Technology & Life Sciences

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

Quick read

von Mehrere Autoren

Call To Action Arrow Image

Newsletter-Anmeldung

Wählen Sie aus unserem Angebot Ihre Interessen aus!

Jetzt abonnieren
Jetzt abonnieren

Related Insights

Patents Technology & Life Sciences

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

9. November 2020
Quick read

von mehreren Autoren

Klicken Sie hier für Details
warsaw
Life Sciences & Healthcare

CJEU ruling to liberalise parallel import in Poland

25. August 2020
IN-DEPTH ANALYSIS

von Dr. Agnieszka Sztoldman

Klicken Sie hier für Details
pills
Coronavirus

Patent law in emergency situations

14. Juli 2020
QUICK READ

von David Mulder

Klicken Sie hier für Details